Pharmacy Geoff (UK) :: Miscellaneous :: VesiBeta 50 (Mirabegron) - 50mg (10 x 10 Tablets)

VesiBeta 50 (Mirabegron) - 50mg (10 x 10 Tablets)

VesiBeta 50 (Mirabegron) - 50mg (10 x 10 Tablets)

Our price: £99.00

Currently out of stock. Contact us if you would like to be notified when this product is back in stock.

VesiBeta 50 (Mirabegron) - 50mg (10 x 10 Tablets)

Uses

VesiBeta 50 (Mirabegron) is a medicine used to treat frequent urination and urinary incontinence. VesiBeta 50 (Mirabegron) increases the average volume of urine during urination and lowers the frequency of urination without contracting the bladder muscles outside the urination without affecting the pressure or residual urine on the bladder cavity. VesiBeta 50 (Mirabegron) enhanced urinary retention by stimulating beta-3 adrenoceptors in the bladder muscles.

Dosage and Administration

Always follow your doctor`s instructions when using VesiBeta 50 (Mirabegron) to get the safest and most effective results from treatment. As a rule, the recommended dose is 50 mg (1 tablet) once a day regardless of food intake.

The tablets must be swallowed whole, washed down with a glass of water, do not chew, crumble or break.

The missed dose should be taken as soon as possible. It is advisable to skip the missed dose if it is already time for your next scheduled dose. Do not use extra medicine to make up for the missed dose.

Side effects

The use of VesiBeta 50 (Mirabegron) may cause side effects in some patients including:

  • tachycardia
  • urinary tract infections
  • nausea
  • constipation
  • diarrhea
  • headache
  • dizziness
  • vaginal infection
  • gastritis
  • dyspepsia

Contact your doctor immediately if you experience any serious or worrying symptoms.

Precautions

Patients with severe hypertension should be under the care of a physician during treatment with VesiBeta 50 (Mirabegron).

There is limited data on the use of VesiBeta 50 (Mirabegron) during pregnancy. It is not recommended to take VesiBeta 50 (Mirabegron) medicine during pregnancy and for women of reproductive age who do not use contraceptives.

The effect of VesiBeta 50 (Mirabegron) on human milk production or its effect on breastfeeding has not been investigated. VesiBeta 50 (Mirabegron) should not be given to women during breastfeeding.

VesiBeta 50 (Mirabegron) does not affect or have little effect on the ability to drive or operate other mechanisms.

Detailed images

Visibeta (Mirabegron) 50mg